Skip to content
A D S Diagnostic logo

A D S Diagnostic

523031 BSE
Price unavailable

In the Jun 2026 quarter, revenue was ₹3.51 Cr, against ₹4.40 Cr a year earlier and net profit was ₹0.03 Cr, against ₹0.15 Cr a year earlier (compared with Jun 2025). Promoters held 45.39% of A D S Diagnostic in Jun 2026, unchanged from Mar 2026.

No price data available

Peer Comparison

Healthcare › Healthcare Services › Healthcare Service Provider

Dr Lal Pathlabs
₹1,905.9058.9331,990 Cr12.750.26%20.06%25.67%2,996 Cr545 Cr
Vijaya Diagnostic Centre
₹1,433.7078.6514,767 Cr15.430.14%18.07%19.22%879 Cr187 Cr
Metropolis Healthcare
₹549.1056.4311,388 Cr7.580.91%12.54%15.73%1,733 Cr203 Cr
Thyrocare Technologies
₹515.7046.548,208 Cr16.012.84%27.79%33.84%894 Cr176 Cr
Nephrocare Health Services
₹630.30150.436,338 Cr5.680.00%6.88%13.46%1,079 Cr85 Cr
Suraksha Diagnostic
₹319.0546.371,662 Cr6.790.16%12.90%14.70%329 Cr35 Cr
Krsnaa Diagnostics
₹494.8016.231,605 Cr1.640.40%10.35%10.64%862 Cr98 Cr
A D S Diagnostic (this company)
———————32 Cr1 Cr
Median 8 companies₹549.1056.438,208 Cr7.580.26%12.90%15.73%887 Cr137 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100. How it works →

No Tapetide Score has been computed for this stock yet.

Key Insights

Strengths

5
  • Stock is trading at 0.33 times its book value
  • Stock is providing a good dividend yield of 10.6%.
  • Company has been maintaining a healthy dividend payout of 17.4%
  • Debtor days have improved from 80.2 to 63.7 days.
  • Company's working capital requirements have reduced from 76.9 days to 61.1 days

Weaknesses

1
  • Company's cost of borrowing seems high

Technical Indicators

Oscillators

Bearish

Bearish
2
Neutral
7
Bullish
0

Overall

Bullish

Bearish
2
Neutral
11
Bullish
6

Moving Averages

Bullish

Bearish
0
Neutral
4
Bullish
6

Growth Rate

Revenue Growth
69% higher than 3Y

change over 1 year

Net Income Growth
9% higher than 3Y

change over 1 year

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
3.25
7.72
7.12
5.95
4.2
5.96
2.6
3.37
4.4
14.59
5.46
4.04
3.51
Expenses
3.09
6.13
6.32
5.26
4.03
5.18
2.23
3.16
4.05
13.57
5
3.76
3.36
Operating Profit
0.16
1.59
0.8
0.69
0.17
0.78
0.37
0.21
0.35
1.02
0.46
0.28
0.15
OPM %
4.92%
20.6%
11.24%
11.6%
4.05%
13.09%
14.23%
6.23%
7.95%
6.99%
8.42%
6.93%
4.27%
Other Income
0
0
0
0
0
0
0
0
0
0
0
0
0
Interest
0.07
0.19
0.16
0.16
0.04
0.12
0.08
0.06
0.12
0.18
0.18
0.13
0.1
Depreciation
0.04
0.04
0.04
0.04
0.04
0.04
0.04
0.03
0.03
0.03
0.02
-0.02
0.01
PBT
0.05
1.36
0.6
0.49
0.09
0.62
0.25
0.12
0.2
0.81
0.26
0.17
0.04
Tax %
0%
22.06%
30%
34.69%
22.22%
24.19%
24%
41.67%
25%
25.93%
23.08%
35.29%
25%
Net Profit
0.04
1.06
0.42
0.33
0.07
0.47
0.19
0.07
0.15
0.61
0.2
0.12
0.03
EPS (₹)
0.18
4.83
1.92
1.5
0.32
2.14
0.87
0.32
0.68
2.78
0.91
0.55
0.14
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
7.44
11.67
5.26
6.38
8.95
13.52
9.43
10.1
13.29
23.96
16
28.49
27.6
Expenses
6.75
10.38
6.01
5.65
7.41
12.96
9.33
9.11
11.79
20.83
14.6
26.38
25.69
Operating Profit
0.69
1.29
-0.75
0.73
1.54
0.56
0.1
0.99
1.5
3.13
1.4
2.11
1.91
OPM %
9.27%
11.05%
-14.26%
11.44%
17.21%
4.14%
1.06%
9.8%
11.29%
13.06%
8.75%
7.41%
6.92%
Other Income
0.11
-0.14
0.82
0.29
0.18
0.81
1.19
0.36
-0.38
0.1
0.13
0
0
Interest
0.31
0.42
0.55
0.51
0.45
0.48
0.56
0.51
0.44
0.57
0.3
0.61
0.59
Depreciation
0.3
0.21
0.16
0.15
0.16
0.27
0.29
0.28
0.19
0.16
0.15
0.06
0.04
PBT
0.19
0.52
-0.64
0.36
1.11
0.62
0.44
0.56
0.49
2.5
1.08
1.44
1.28
Tax %
57.89%
42.31%
-18.75%
41.67%
22.52%
24.19%
25%
23.21%
16.33%
26%
25.93%
26.39%
—
Net Profit
0.08
0.31
-0.52
0.21
0.85
0.47
0.34
0.44
0.41
1.85
0.81
1.07
0.96
EPS (₹)
0.36
1.41
-2.37
0.96
3.88
2.14
1.55
2.01
1.87
8.44
3.69
4.88
4.38
Div. Payout %
0%
0%
0%
0%
23.82%
0%
0%
40.91%
0%
0%
27.78%
24.56%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
2.25
2.25
2.25
2.25
2.25
2.25
2.25
2.25
2.25
2.25
2.25
2.25
Reserves
-0.1
0.21
-0.31
-0.1
0.77
1.07
1.41
1.85
2.13
3.77
4.34
5.2
Borrowings
2.19
4.45
4.19
3.79
1.81
5.51
5.29
3.99
2.54
2.08
2.31
3.1
Other Liabilities
2.67
7.17
2.35
4.18
11.93
8.54
5.63
3.92
5.05
7.83
10.25
12.31
Total Liabilities
7.01
14.08
8.48
10.12
16.76
17.37
14.58
12.01
11.97
15.93
19.15
22.86
Fixed Assets
1.06
1.58
1.38
1.11
2.1
1.84
1.55
1.15
0.37
0.22
0.26
0.28
CWIP
0
0
0
0
0
0
0
0
0
0
0
0
Investments
0
0
0.04
0.04
0.04
0.04
0.04
0.04
0.04
0.04
0.04
0.04
Other Assets
5.95
12.5
7.06
8.97
14.62
15.49
12.99
10.82
11.56
15.67
18.85
22.54
Total Assets
7.01
14.08
8.48
10.12
16.76
17.37
14.58
12.01
11.97
15.93
19.15
22.86
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
1.16
1.14
-1.6
0.89
3.82
-3.98
0.53
1.74
1.44
1.99
0.78
-0.04
Investing
-1.15
-0.88
0.62
0.15
-1.07
0.08
0.09
0.24
0.68
0.06
-0.12
0.06
Financing
-0.22
-0.5
1.13
0.09
-2.35
2.83
-0.09
-2
-3.18
-1.22
-0.34
-0.04
Net Cash Flow
-0.21
-0.23
0.15
1.13
0.41
-1.07
0.53
-0.03
-1.06
0.83
0.31
-0.02
Free Cash Flow
0.44
0.06
-1.46
0.93
2.67
-3.99
0.52
1.91
2.06
1.98
0.57
-0.11
CFO/OP
186
105
191
127
260
-684
530
187
113
79
97
13
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
60.34
183
136
127
106
138
175
124
75.53
78.76
98.09
63.67
Inventory Days
238
196
284
—
—
—
—
—
281
186
469
279
Days Payable
201
204
161
—
—
—
—
—
172
79.83
382
174
Cash Conversion Cycle
97.07
176
259
127
106
138
175
124
184
185
185
169
Working Capital Days
-50.53
-34.4
-4.86
0.57
-30.99
25.38
58.83
57.1
74.7
67.33
102
61.11
ROCE %
12.24%
22.93%
-0.77%
15.74%
28.97%
16.11%
11.25%
12.09%
23.85%
40.88%
16.24%
21.09%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view A D S Diagnostic insights

65 extracted metrics + investor summaries across FY09–FY27.

Shareholding Pattern

Public50.03%DIIs4.57%Promot.45.39%As ofJun 2026

Documents

Frequently Asked Questions about A D S Diagnostic

What does A D S Diagnostic Ltd do?
ADS Diagnostic supplies and trades medical equipment. The Company offers patient monitoring systems and ultrasound machines.
Where is A D S Diagnostic Ltd (ADSDIAG) listed?
A D S Diagnostic Ltd trades under code 523031 on the BSE.
Which sector does A D S Diagnostic Ltd belong to?
A D S Diagnostic Ltd is classified under the Healthcare sector, in the Healthcare Services industry.

Company Information

ADS Diagnostic supplies and trades medical equipment. The Company offers patient monitoring systems and ultrasound machines.

Website adsdiagnosticltd.com
Listed 2006-04-17
Face Value ₹ 10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/523031.md for A D S Diagnostic Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Hospital & Healthcare Services stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month